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Objective: This study aimed to determine the expression, clinical significance, and possible 
biologic function of microRNA-324-3p in nasopharyngeal carcinoma (NPC) tissues.
Methods: In total, 54 NPC and 35 control tissues were collected. The correlation between 
miR-324-3p expression and the clinicopathologic characteristics was analyzed. A dual-luciferase 
reporter gene assay was employed to examine the predicted target gene of miR-324-3p. 
The miR-324-3p expression level in 5–8F cells was determined with quantitative reverse 
transcription-polymerase chain reaction following the transfection of miR-324-3p mimics and 
inhibitors. Cell proliferation and the percentage of apoptosis were measured with MTT and flow 
cytometry. Cell invasion ability was assessed by Transwell invasion assay.
Results: Our results showed that miR-324-3p was downregulated in the NPC tissues. The 
expression level of miR-324-3p in poorly differentiated NPC was significantly reduced in 
comparison with that in well/moderately differentiated NPC. The expression level in clinical 
stages III/IV was lower than that in clinical stages I/II. Moreover, the expression level of 
miR-324-3p was significantly lower in NPC patients with lymph node metastasis than that in 
NPC patients without lymph node metastasis. NPC patients with higher levels of miR-324-3p 
expression also demonstrated a longer survival time. Predictions from bioinformatics indicated 
the Hedgehog pathway transcription gene GLI3 as the target gene of miR-324-3p, and the dual-
luciferase reporter assay showed that miR-324-3p is directly combined with the 3′-untranslated 
region of GLI3. The overexpression of miR-324-3p suppressed cell proliferation and invasion, 
and it enhanced apoptosis in 5–8F cells.
Conclusion: miR-324-3p can act as a tumor suppressor in NPC cells by the negative regula-
tion of GLI3 gene.
Keywords: nasopharyngeal carcinoma, microRNA, invasion, prognosis, survival
Introduction
Nasopharyngeal carcinoma (NPC) cases were observed to mainly occur in the southern 
provinces of China and Southeast Asia, while they rarely occur in Europe, the USA, 
and northern China.1 It is believed that the occurrence of NPC is associated with an 
Epstein–Barr virus infection, diet, geography, and heredity. Furthermore, previous 
studies have shown that NPC is controlled by multiple genes, pathways, and pathologic 
processes.2,3 After decades of research, significant progress has been made in the etiol-
ogy of NPC. However, the specific mechanisms of this disease remain unclear.
miRNA refers to a small noncoding RNA encoded by an endogenous gene with a 
length of about 19–25 bp. These miRNAs are able to recognize specific target mRNAs 
at posttranscriptional levels by promoting mRNA degradation and/or inhibiting 
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the translation process, thereby negatively regulating the 
expressions of target genes.3 In addition, miRNAs also 
participate in a series of processes, such as development, 
hematopoiesis, fat metabolism, organogenesis, cell prolifera-
tion, differentiation, and apoptosis, which are quintessential 
for organisms.2 Hence, miRNA expression disorders or dys-
functions may lead to the occurrence of a variety of diseases, 
including tumors. Many studies have shown that miRNAs 
also play a vital role as oncogenes or tumor suppressor 
genes in tumor cell proliferation, apoptosis, differentiation 
regulation, tumor development, and biologic functions.2,4 
For example, the miR-34 family is directly regulated by 
p53 and is involved in p53-dependent tumor suppressor 
p21-dependent pathways,5,6 and its expression is often 
reduced in the pancreas, colon, and neuroblastomas.7–9 The 
expression of let-7 is restricted by the regulation of K-Ras 
and is closely related to the prognosis of lung cancer.10,11 
In addition, miR-182 is highly expressed in melanomas, 
and its function is to inhibit the expression of FOXO3 and 
MIF, which promote melanoma metastasis.12
At present, the literature on the role of miR-324-3p in 
the function and mechanism of NPC tumor is undefined, 
and its role in NPC tumor invasion and metastasis has not 
been reported. In this study, the expression of miR-324-3p in 
NPC tissues and control nasopharyngeal mucosa (including 
normal and inflammatory mucosa) was detected, and the 
relationship between miR-324-3p and clinical parameters, 
such as the clinical stage, metastasis, and prognosis of NPC, 
were evaluated. Further in vitro studies were conducted to 
reveal the role of miR-324-3p in NPC and to discover new 
diagnostic and prognostic molecular markers.
Materials and methods
specimen collection
All clinical biopsy tissues, including 54 cases of NPC 
(36 males and 18 females) and 34 cases of normal 
and chronic inflammatory nasopharyngeal mucosal biopsy 
tissues (21 males and 13 females), were collected from 
July 2006 to October 2015 from the Guizhou Provincial 
People’s Hospital. The biopsy tissues were immediately 
stored in liquid nitrogen. All biopsy specimens were 
confirmed by pathology. NPC and poorly differentiated 
squamous cell carcinoma was determined in 49 cases, 
whereas a high/moderate differentiation of squamous cell 
carcinoma was determined in 5 cases. According to the TNM 
classification of malignant tumors, three cases were clinical 
stage I, 17 were clinical stage II, 23 were clinical stage III, 
and 11 cases were clinical stage IV. Lymph node metastasis 
was found in 42 cases and no lymph node metastasis was 
determined in 12 cases.
ethics statement
The study was approved by the Ethics Committee of the 
Guizhou Provincial People’s Hospital. Written informed 
consent was obtained from each patient prior to surgery. All 
experimental procedures were carried out in accordance with 
the approved guidelines and the Declaration of Helsinki.
cell culture
The 5–8F NPC cell line was purchased from the cell bank 
at the Chinese Academy of Sciences (Beijing, China). Cells 
were cultured in RPMI-1640 (Thermo Fisher Scientific, 
Waltham, MA, USA) supplemented with 10% fetal bovine 
serum (FBS; Thermo Fisher Scientific) and incubated at 
37°C in a humidified 5% CO
2
 atmosphere.
cell proliferation and apoptosis
MTT assay was used to measure cell proliferation rate 
at 0, 24, 48, 72, and 96 h following the manufacturer’s 
instructions (Sigma-Aldrich Co., St Louis, MO, USA). Cell 
apoptosis was determined using the Annexin V-fluorescein 
isothiocyanate/propidium iodide apoptosis detection kit 
(Thermo Fisher Scientific) and analyzed using flow cytometer 
(BD Biosciences, San Jose, CA, USA).
luciferase assay
The single purification wild-type or mutant 3′-untranslated 
region (3′-UTR) seeding region sequence of GLI3 was 
transfected into pGL3 reporter (Promega, Madison, WI, 
USA). Then, the established reporter and the 50 nM miRNA 
inhibitor or mimic were cotransfected into 5–8F cells. 
A commercial dual-luciferase assay kit (Promega) was used 
to detect luciferase activity following transfection for 24 h.
Quantitative reverse transcription-
polymerase chain reaction (qrT-Pcr)
Mature miRNA-324-3p expression in cells was detected by 
using TaqMan miRNA assays (Thermo Fisher Scientific) 
in an ABI 7500 real-time PCR system. The RT and PCR 
primers for miRNA-324-3p were purchased from Thermo 
Fisher Scientific. cDNA transcription process was performed 
using commercial kits (Takara, Tokyo, Japan). The condition 
of TaqMan determination was as follows: 95°C for 10 min, 
40 cycles for 15 sec at 95°C, and for 60 sec at 60°C. U6 was 
chosen as the internal control. The relative miRNA levels 
were calculated using 2-ΔΔCt method.
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Plasmid construction and cell transfection
The miRNA-324-3p mimic, miR-324-3p inhibitor, and 
negative control (Thermo Fisher Scientific) were trans-
fected into 5–8F using Lipofectamine 2000 (Thermo Fisher 
Scientific) to enhance or inhibit miRNA-324-3p expression 
in cells. A qRT-PCR was utilized to confirm the expression 
of miRNA-324-3p.
Western blot analysis
Protein samples were prepared with a lysis buffer by adding 
protease and phosphatase inhibitors (Thermo Fisher Sci-
entific). These proteins were separated by sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis and then trans-
ferred to nitrocellulose membranes under a semi-dry system 
(Bio-Rad Laboratories, Inc., Hercules, CA, USA). Next, the 
membranes were blocked with primary antibodies overnight 
at 4°C. Following two continuous washing, the membranes 
were then incubated with secondary antibodies. All anti-
bodies including E-cadherin (1:500), vimentin (1:500), and 
β-actin (1:5,000) were purchased from Santa Cruz Company 
(Santa Cruz, CA, USA). Protein expression was visualized 
with a gel image system (Bio-Rad Laboratories Inc.).
Wound healing assay
To assess the ability of the cell migration, 5–8F cells (1×106) 
were seeded in six-well plates (Corning Life Sciences, 
Corning, NY, USA) supplemented with RPMI-1640 which 
contained 10% FBS. A wound was then created in the center 
of the cell monolayer using a sterile plastic pipette tip (Corn-
ing Life Sciences). The cells were incubated at 37°C in a 
humidified 5% CO
2
 atmosphere for 72 h to heal the wound. 
An inverted microscope (Nikon Eclipse Ti; Nikon, Tokyo, 
Japan) was used to capture images of the cells at 0 and 72 h 
after wounding.
Transwell invasion assay
5–8F cells (1×106) cultured in 200 μL serum-free RPMI-
1640 medium were seeded onto the upper chambers of 
Matrigel®-coated Transwell® filters (pore size, 8 μm; Corning 
Life Sciences). Five hundred microliters of RPMI-1640 
containing 10% FBS was added to the lower chambers as 
a chemoattractant. Following 24 h incubation at 37°C in a 
humidified 5% CO
2
 atmosphere, cells that had successfully 
invaded through the inserts were fixed in 4% paraformalde-
hyde for 30 min and stained with methylrosanilinium chloride 
(Sigma-Aldrich Co.). Five preselected microscopic fields 
were utilized to count the number of invaded cells (magnifica-
tion, ×200). All experiments were repeated in triplicate.
statistical analysis
SPSS 13.0 (SPSS Inc, Chicago, IL, USA) was used to sta-
tistically analyze the data obtained in this study. Numerical 
data are represented as mean ± SD. Statistical analysis was 
carried out using the Student’s t-test to evaluate the statisti-
cal differences between normal and gene knock-down cells. 
The χ2 test was used to compare the percentage distribution 
in different groups. Fisher’s test was performed in cases 
when the number of cells obtained was ,5. Each experiment 
was repeated at least twice or was performed in triplicate. 
Kaplan–Meier survival curve was used to analyze the rela-
tionship between miR-324-3p expression and prognosis. 
P-value ,0.05 was considered statistically significant.
Results
expression of mir-324-3p in nPc and 
its relationship with clinical features and 
prognosis
Our study extracted total RNA from 54 cases of NPC and 
34 cases of nasopharyngeal mucosa. The relative expres-
sion of miR-324-3p was detected using the qRT-PCR 
method. The results showed that miR-324-3p expression 
was downregulated in the NPC tissues compared with the 
control nasopharyngeal epithelium (Figure 1A). The average 
expression of miR-324-3p in NPC (2.35±0.33) ×10-3 was sig-
nificantly lower compared to that in nasopharyngeal mucosa 
(7.87±1.02) ×10-3. The average expression of miR-324-3p 
was about 3.3 times that of NPC (P,0.05). The difference 
obtained was statistically significant (P=0.000).
As shown in Table 1, the expression of miR-324-3p was 
significantly lower in poorly differentiated squamous cell 
carcinoma than in high/moderately differentiated squamous 
cell carcinoma (P=0.032). The expression of miR-324-3p 
was significantly lower in clinical stage III/IV NPC than in 
clinical stage I/II NPC (P=0.007). The expression of miR-
324-3p was significantly lower in metastatic NPC than that 
in NPC without lymph node metastasis (P=0.019), which 
indicated that the miR-324-3p expression may be closely 
related to the clinical progression, metastasis, and pathologic 
differentiation of NPC. In addition, the expression level 
of miR-324-3p was unrelated to the age and/or sex of the 
patients with NPC (P.0.05).
Among the 54 patients with NPC, 51 patients were 
followed up in the study (3 patients with NPC lost contact, 
leading to a loss rate of 0.06%). The follow-up time was 
4 months, and the longest follow-up time was 62 months. 
Of the patients who were followed up, 23 patients showed 
a relatively low expression of miR-324-3p and 9 patients 
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died, giving a mortality rate of 39.1%. In total, 28 patients 
demonstrated a relatively high level of miR-324-3p and 
8 cases died, giving a mortality rate of 10.7%. The Kaplan–
Meier survival analysis (log-rank test) found that the average 
survival time was significantly higher in the miR-324 high-
expression group than in the miR-324 low-expression group 
(P=0.016; Figure 1B). The average survival time was 58.5 
and 36.3 months, respectively. Thus, our results suggest that 
a higher expression level of miR-324 among NPC patients 
can lead to a longer survival time and may deliver a better 
prognosis for patients afflicted with NPC.
effects of mir-324-3p-3p expression on 
the migration and invasion of nPc cells
To further elucidate the effect of miR-324-3p on the migra-
tion and invasion of NPC, we first used an miR-324-3p 
mimic to upregulate its expression in NPC cells. The results 
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Figure 1 correlation between mir-324-3p expression and clinical features of nPc.
Notes: (A) The expression levels of miR-324-3p in 54 NPC tissues and 35 control tissues with no NPC (normal nasopharyngeal mucosa or chronic inflammation of 
nasopharyngeal mucosa) were detected by qrT-Pcr. The relative expression level of mir-324-3p was calculated using 2-ΔΔct method. mir-324-3p was downregulated in 
nPc tissues. (B) The correlation of mir-324-3p expression in nPc tissues and the overall survival of patients were analyzed by the Kaplan–Meier method.
Abbreviations: cum, cumulative; nPc, nasopharyngeal carcinoma; qrT-Pcr, quantitative reverse transcription-polymerase chain reaction.
Table 1 The relationship between mir-324-3p expression and 
the clinicopathologic characteristics in nPc patients
Variable Cases 
(n)
Average expression 
of miR-324-3p
P-value
sex 0.647
Male 36 2.48±0.45
Female 18 2.16±0.52
age (years) 0.528
$60 14 2.51±0.53
,60 40 2.17±0.48
Degree of differentiation 0.032
Well and moderately 5 3.47±0.71
Poorly 49 1.55±0.52
TnM stage 0.007
i–ii 20 3.85±0.59
iii–iV 34 1.02±0.47
lymph node status 0.019
Metastasis 42 1.41±0.50
no metastasis 12 3.56±0.61
Abbreviation: nPc, nasopharyngeal carcinoma.
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of qPCR showed that the expression of miR-324-3p in NPC 
5–8F cells was significantly upregulated after 48 min of 
mimic transfection compared to the control (Figure 2A). 
The scratch healing experiments showed that the scratch 
healing ability of 5–8F cells was significantly decreased 
compared to the blank control group and the negative control 
group (Figure 2B). Furthermore, we confirmed the effect of 
miR-324-3p on NPC cell invasion ability. The data showed 
that the cells passing through the polycarbonate membrane 
were significantly lower than those in the blank control group 
and the negative control group after the overexpression of 
miR-324-3p (Figure 2C). To elucidate the molecular mecha-
nism of the regulation of NPC cell invasion and metastasis 
by miR-324-3p, we examined the expression of E-cadherin 
and vimentin. The results from the Western blot analysis 
showed that the expression of E-cadherin was increased 
in NPC 5–8F cells, while the expression of vimentin was 
downregulated (Figure 2D; P,0.05). The results highlight 
that miR-324-3p can promote the invasion and metastasis of 
NPC cells by inducing changes in epithelial–mesenchymal 
transition (EMT).
effect of mir-324-3p on the cell 
proliferation and apoptosis of nPc cells
To investigate further the role of miR-324-3p in cell pro-
liferation and the apoptosis process, 5–8F NPC cells were 
transfected with an miR-324-3p mimic and cultured for a 
period of 96 h. The cell proliferation rate was determined 
at 0, 24, 48, 72, and 96 h. The MTT results demonstrated a 
significantly decreased cell proliferation rate in cells with 
an overexpression of miR-324-3p (Figure 3A). In addition, 
enhanced cell apoptosis percentage was observed in the 
miR-324-3p transfected group in comparison with the control 
group (Figure 3B and C).
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Figure 2 effects of mir-324-3p-3p expression on migration and invasion of nasopharyngeal carcinoma cells.
Notes: (A) The results of qPCR showed that the expression of miR-324-3p in nasopharyngeal carcinoma 5–8F cells was significantly upregulated following 48 h transfection 
compared to the control. (B) The scratch healing experiments showed that 5–8F scratch healing ability was significantly decreased than the blank control group and 
negative control. (C) The data showed that the number of cells passing through the polycarbonate membrane was significantly lower in the miR-324-3p group than that in 
the blank control and the negative control group. (D) Western blot results showed that the expression of e-cadherin was increased, while the expression of vimentin was 
downregulated in nasopharyngeal carcinoma 5–8F cells. *P,0.05, compared to control cells.
Abbreviations: nc, negative control; qPcr, quantitative polymerase chain reaction.
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gli3 as the target gene of mir-324-3p 
regulated nPc cell invasion
The target genes of hsa-miR-324-3p were predicted using 
the TargetScan, PicTar, and MicroRNA.org databases. The 
intersection of three software predictions was selected as 
possible target genes, where miR-324-3p is a conserved 
species and the seven bases (GAGAUGA) in its “seed 
region” are completely complementary to the 3′-UTR 
(TCATCTC) of GLI3. In addition, the free energy between 
miR-324-3p and GLI3 is relatively low. Thus, from the 
perspective of bioinformatics, it can be predicted that 
GLI3 may act as the target gene for miR-324-3p. To con-
firm this prediction, our experiment constructed the GLI3 
3′-UTR expression vector and its mutant vector. Luciferase 
results confirmed that miR-324-3p could regulate the 
expression of the GLI3 gene. The expression of luciferase 
activity in the miR-324-3p/psiCHECK-2-GLI3-3′-UTR 
group was significantly inhibited, while the activity of 
miR-324-3p/psiCHECK-2-GLI3-Mut-3′-UTR and NC/
psiCHECK-2-GLI3-Mut-3′-UTR did not exhibit signifi-
cant changes (Figure 4A). Further, the expression of GLI3 
protein was significantly lower in the miR-324-3p inhibitor 
group than that in the control group (Figure 4B). In contrast, 
the expression of GLI3 protein was significantly higher 
in the miR-324-3p mimic group than that in the control 
group (Figure 4C). Our results showed that miR-324-3p 
negatively correlated with GLI3 expression in 5–8F cells. 
We found in our previous study that an miR-324-3p mimic 
could decrease the migration and invasion ability of NPC 
cells (Figure 2C). After knocking down the GLI3 genes with 
siRNA (Figure 4D), the Transwell assay results showed 
that the number of transmembrane cells was significantly 
lower in 5–8F cells than that in the NC group (Figure 4E). 
In short, the results indicate that miR-324-3p may inhibit 
the invasion of 5–8F cells through a negative regulatory 
GLI3 expression.
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Figure 3 effect of mir-324-3p on cell viability and apoptosis.
Notes: (A) Cell proliferation rates were detected with MTT method. miR-324-3p significantly suppressed cell proliferation compared to control cells. (B) mir-324-3p mimic 
significantly induced cell apoptosis in 5–8F nasopharyngeal carcinoma cells. (C) The apoptosis results presented were obtained from Becton, Dickinson and company (BD) 
flow cytometry software. Three independent experiments were performed. Data are shown as mean ± sD. *P,0.05 compared to control cells.
Abbreviation: nc, negative control.
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Discussion
In this study, the expression of miR-324-3p in NPC tissue 
samples was detected and the clinical significance of miR-
324-3p was analyzed. Results showed that the expression 
of miR-324-3p in NPC was significantly lower than in the 
control nasopharyngeal epithelium. The expression of miR-
324-3p was also significantly lower in poorly differentiated 
NPC than that in the control nasopharyngeal epithelium. 
Moreover, the expression of miR-324-3p was significantly 
lower in NPC with lymph node metastasis than that in the 
non-lymph node metastasis group with NPC. Overall, the 
results showed that miR-324-3p expression was negatively 
correlated with the clinical progress and metastasis of NPC, 
while it was positively correlated with the pathologic degree. 
The survival time of NPC patients with higher miR-324-3p 
expression levels was significantly longer compared to that 
in patients with lower miR-324-3p levels. The results implied 
that variations in the miR-324-3p level in NPC and control 
nasopharyngeal epithelial tissues could serve as cancer gene 
regulators that are involved in the occurrence and develop-
ment of NPC. NPC is a highly malignant tumor that causes 
death through distant metastasis. Therefore, it is vital to iden-
tify effective molecular indicators that can guide the diagnosis 
and treatment of NPC, as well as reduce distant metastasis 
from the nasopharynx. The detection of miR-234-3p may 
become a new part of NPC diagnosis. Moreover, this study 
may give rise to novel treatments for NPC with new emerging 
targets that can promote better prognosis for NPC patients.
A new type of gene regulator, miRNA, is closely related 
to tumor occurrence and development. It is mainly involved 
in the regulation of the posttranscriptional levels of genes. 
The miRNAs are complementary to the 3′-UTR of their target 
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Figure 4 gli3 as the target gene of mir-324-3p-regulated nPc cell invasion.
Notes: (A) Luciferase results confirmed that miR-324-3p could directly regulate the expression of GLI3 gene. The luciferase activity in cells containing wild-type GLI3-3′-UTr 
was significantly inhibited, compared to cells with mutant form of GLI3-3′-UTr and control cells. (B) The GLI3 protein level in miR-324-3p mimic group was significantly 
lower than that in the control group. (C) The GLI3 protein level in miR-324-3p inhibitor group was significantly higher than that in the control group. (D) The knock-down 
efficiency of GLI3 genes was evaluated with qRT-PCR and Western blot. (E) The Transwell assay results showed that the number of transmembrane cells in 5–8F cells was 
significantly lower than that in the control group. Three independent experiments were performed. Data are shown as mean ± sD. *P,0.05 compared to the control cells.
Abbreviations: nc, negative control; nPc, nasopharyngeal carcinoma; qrT-Pcr, quantitative reverse transcription-polymerase chain reaction; UTr, untranslated region.
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mRNA molecules and they regulate the degradation of their 
target mRNA or inhibit its translation.13 Recent studies have 
shown that miRNAs play a pivotal role in the pathogenesis of 
various types of tumors, including NPC. In addition, miRNAs 
can regulate their downstream target genes, which affects 
the biologic behavior of tumor cells, such as proliferation, 
apoptosis, differentiation, movement, invasion, metastasis, 
and angiogenesis. Therefore, it is important to investigate the 
role of miRNA in tumorigenesis to enhance our knowledge 
on tumor diagnosis, treatment, and prognosis.14,15
Many studies have focused on the correlation between 
the serologic expression of miR-324-3p and the pathologic 
parameters of different diseases. Cui et al16 reported that miR-
324-3p in combination with five other miRNAs (miR-148a, 
miR-143, miR-628-3p, miR-140-5p, and miR-362-3p) in 
the serum can help distinguish the diagnosis of enterovirus 
71 and Coxsackie virus 16, which is caused by hand, foot, 
and mouth infection. In addition, renal fibrosis studies have 
shown that miR-324-3p can be targeted to reduce the PREP 
protein, which promotes renal disease progression in renal 
fibrosis.17 In the tumor study, Hu et al18 found the expression 
of miR-324-3p and three other miRNAs (miR-16, miR-25, 
and miR-222) to be significantly decreased in the serum of 
breast cancer patients. Greenberg et al19 found the obvious 
absence of miR-324-3p in the serum of patients with 
malignant melanoma, which can be an indicator of disease 
progression. In hepatocellular carcinoma,20 miR-324-3p can 
serve as an early marker of liver cancer. A recent study has 
shown that miR-324-3p can play a regulatory role in the 
radiotherapy resistance of NPC through regulating its target 
gene, SMAD7.21 However, functional research studies on 
miR-324-3p in NPC have not yet emerged.
In this study, we found that upregulated miR-324-3p 
could significantly affect the cell proliferation and apoptosis 
process. Moreover, the migration and invasion of NPC cells 
were also inhibited by regulating the EMT process. At present, 
tumor cell EMT changes are believed to be related to cancer 
invasion and metastasis.22 The EMT process includes 
changes in the morphology and gene expressions of epithe-
lial cells to interstitial cells, which is often associated with 
the downregulation of the epithelial cell marker E-cadherin 
and the upregulation of the interstitial cell marker vimentin.
Thus, an important question that arises from our study 
is how miR-324-3p obtains its regulatory function by 
binding to its target gene. At present, the main method of 
identifying the miRNA target gene is to predict the target 
gene using bioinformatics prediction software, such as 
TargetScan, PicTar, and MicroRNA.org. In our study, the 
bioinformatics software predicted that the target gene of 
miRNA-324-5p is the GLI3 gene. However, bioinformatics 
often predicts a large false positive for miRNA target genes, 
whereas miRNAs are complementary to the 3′-UTR of 
target mRNA by inhibiting mRNA translation or directly 
degrading mRNA,23,24 which can lead to inhibition of protein 
synthesis.25 To avoid the false-positive results, we investi-
gated the binding effect of miR-324-3p and GLI3 with the 
dual-luciferase reporter assay. The dual-luciferase assay 
showed that miR-324-3p was able to directly modulate the 
3′-UTR of GLI3. However, the dual-luciferase reporter gene 
system was unable to determine whether the GLI3 protein 
expression was inhibited; hence, miR-324-3p mimics and 
miR-324-3p inhibitors were transfected into 5–8F cells. 
The cells were detected by the Western blot method, and 
the expression levels of miR-324-3p and GLI3 in 5–8F cells 
were confirmed to be negatively correlated. Furthermore, 
the results further indicated that GLI3 was the target gene 
of miR-324-3p. In addition, the results from the Transwell 
invasion showed that the invasion ability of 5–8F cells was 
significantly decreased after the overexpression of miR-
324-3p or interference with endogenous GLI3.
GLI3 (Homo sapiens GLI family zinc finger 3) is located 
on chromosome 7p13 and is a member of the GLI family. 
GLI3 is a downstream gene of the Hedgehog-GLI (HH-GLI) 
signaling pathway, which was discovered by Ruppert et al 
in 1988.26 Some studies have found that the Hedgehog (Hh) 
signaling pathway is directly related to the occurrence and 
development of tumors, and the transcription factor GLI3 
can be used as a marker gene for Hh signaling pathway 
activation.27 In the Hh signaling pathway, the transmembrane 
protein PTCH forms a complex with Smo and inhibits its 
activity. When the ligand Hh binds to the PTCH receptor, 
the PTCH-Smo complex is dissociated, which results in the 
activation of Smo. The downstream gene of GLI family regu-
lates gene transcription, thereby activating the Hh signaling 
pathway. In short, the results suggested that miR-324-3p may 
affect the expression of GLI3 and result in inhibition of the 
invasion ability of 5–8F cells.
Conclusion
This study suggests that the expression of miR-324-3p may 
relate to the carcinogenesis, progression, and prognosis of 
NPC. As well, miR-324-3p can inhibit the invasion of NPC 
cells through the negative regulation of GLI3 gene, which 
sheds light on the role of miR-324-3p and the Hh pathway 
in NPC. In the future, our study could be utilized to provide 
a clinical benefit to NPC, as miR-324-3p can be used as a 
potential therapeutic target, a diagnostic biomarker, and/or 
a prognostic predictor.
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